2013
Exploring the Role of Antithrombin Replacement for the Treatment of Preeclampsia: A Prospective Randomized Evaluation of the Safety and Efficacy of Recombinant Antithrombin in Very Preterm Preeclampsia (PRESERVE‐1)
Paidas MJ, Sibai BM, Triche EW, Frieling J, Lowry S, Group T. Exploring the Role of Antithrombin Replacement for the Treatment of Preeclampsia: A Prospective Randomized Evaluation of the Safety and Efficacy of Recombinant Antithrombin in Very Preterm Preeclampsia (PRESERVE‐1). American Journal Of Reproductive Immunology 2013, 69: 539-544. PMID: 23444920, DOI: 10.1111/aji.12091.Peer-Reviewed Original ResearchConceptsProspective Randomized EvaluationAntithrombin replacementWeeks' gestationRandomized EvaluationRecombinant antithrombinTreatment of preeclampsiaRecombinant human ATExpectant managementPreterm preeclampsiaPrimary endpointMaternal indicationsGestational ageStudy enrollmentAT therapyPreeclampsia studyPreeclampsiaGestationHuman ATAT replacementPharmacokinetic activityAntithrombinEfficacySafetyLaboratory assaysDelivery
2010
Disseminated Intravascular Coagulation
Hossain N, Paidas M. Disseminated Intravascular Coagulation. 2010, 182-194. DOI: 10.1002/9781444328332.ch10.Peer-Reviewed Original ResearchDisseminated intravascular coagulationIntravascular coagulationEndothelial damageBlood productsAmniotic fluid embolismTransfusion of bloodAbruptio placentaeObstetric patientsHemorrhagic shockSystemic activationPrimary disorderFluid balanceIntravascular thrombiCoagulation factorsMultidisciplinary approachPregnancyPatientsObstetricsCoagulationBloodDisordersCorrect useLaboratory assaysConsequences of consumptionCoagulopathy